OrthoPediatrics Conference Call Summary Company Overview - **Company**: OrthoPediatrics (NasdaqGM: KIDS) - **Industry**: Pediatric orthopedic medical devices Key Points and Arguments New Product Cycle and Super Cycle - OrthoPediatrics is entering a "Super Cycle" with a series of new product launches that will significantly impact financial performance in the coming years [2][3] - The company has expanded its product offerings from 17 systems at the time of going public in 2017 to 87 systems today, including both surgical and bracing options [4][5] Product Innovations - **Trauma and Deformity (T&D)**: This segment accounts for approximately 70% of sales. Recent launches include: - Pediatric nailing platform with femur and tibia products, with a retrograde product in development [7][8] - 3P pediatric plating platform, including the 3P Hip launched in 2025 and additional systems expected in 2026-2028 [19] - **Scoliosis Products**: - Launch of VertiGlide, which allows for growth while correcting curvature, expected to ramp up in 2026 [20][22] - eLLi, a growing spine rod that expands mechanically, with first human trials planned for fall 2026 [23] - **Enabling Technology**: - Playbook, a device for OR efficiency, and iotaMotion, a small robot for cochlear implants, are also in development [37] - **Bracing Products**: OPSB specialty bracing business is expected to grow over 20% annually, with plans to expand clinic locations [50][51] Financial Performance and Cash Flow - Expected free cash flow to be positive in 2026, driven by: - Increased EBITDA from $15 million in 2025 to $25 million in 2026 [45] - More efficient product sets and improved selling prices [46] - Focus on working capital management, including accounts receivable and inventory improvements [46] Competitive Landscape - The company is experiencing reduced competition due to larger companies pulling products from the market, particularly in the trauma and deformity segment, due to EU MDR regulations [62][68] - OrthoPediatrics is positioned to fill the gap left by competitors, with new and improved solutions ready for launch [69] Sales Force and Talent Acquisition - The company has no issues attracting talent, particularly from other specialties, to support its pediatric focus [61] - The competitive landscape has created opportunities for OrthoPediatrics to recruit skilled sales personnel [60] Future Growth and Market Position - OrthoPediatrics aims to serve all segments of pediatric orthopedics, with potential expansion beyond orthopedic products [71] - The company is not currently viewed as a takeover candidate, as it seeks to maintain its unique culture and operational focus [70] Additional Important Information - The 7D navigation device for scoliosis procedures is a significant innovation, offering zero radiation navigation, which is highly favored by surgeons [55][56] - The company is exploring various sales models for its products, including direct sales, consignment, and leasing options [56] This summary encapsulates the key insights from the OrthoPediatrics conference call, highlighting the company's strategic direction, product innovations, financial outlook, and competitive positioning in the pediatric orthopedic market.